+1 347 708 0418
The Drugs of Abuse Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Drugs of Abuse Testing size is estimated to be USD 3516 million in 2026 from USD 2957.6 million in 2020, with a change XX% between 2020 and 2021. The global Drugs of Abuse Testing market size is expected to grow at a CAGR of 4.4% for the next five years.
Market segmentation
Drugs of Abuse Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Psychostimulants
Narcotic
Hallucinogens
Sedatives
Others
Market segment by Application, can be divided into
Hospitals
Diagnostics Laboratories
Forensic Laboratories
Others
Market segment by players, this report covers
Quest Diagnostics
F. Hoffmann La-Roche
Siemens
Thermo Fisher Scientific
Abbott
Shimadzu
Laboratory Corporation of America
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Drugs of Abuse Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Drugs of Abuse Testing, with revenue, gross margin and global market share of Drugs of Abuse Testing from 2019 to 2021.
Chapter 3, the Drugs of Abuse Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Drugs of Abuse Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Drugs of Abuse Testing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Drugs of Abuse Testing
1.2 Classification of Drugs of Abuse Testing by Type
1.2.1 Overview: Global Drugs of Abuse Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Drugs of Abuse Testing Revenue Market Share by Type in 2020
1.2.3 Psychostimulants
1.2.4 Narcotic
1.2.5 Hallucinogens
1.2.6 Sedatives
1.2.7 Others
1.3 Global Drugs of Abuse Testing Market by Application
1.3.1 Overview: Global Drugs of Abuse Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Forensic Laboratories
1.3.5 Others
1.4 Global Drugs of Abuse Testing Market Size & Forecast
1.5 Global Drugs of Abuse Testing Market Size and Forecast by Region
1.5.1 Global Drugs of Abuse Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Drugs of Abuse Testing Market Size by Region, (2016-2021)
1.5.3 North America Drugs of Abuse Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Drugs of Abuse Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Drugs of Abuse Testing Market Size and Prospect (2016-2026)
1.5.6 South America Drugs of Abuse Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Drugs of Abuse Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs of Abuse Testing Market Drivers
1.6.2 Drugs of Abuse Testing Market Restraints
1.6.3 Drugs of Abuse Testing Trends Analysis
2 Company Profiles
2.1 Quest Diagnostics
2.1.1 Quest Diagnostics Details
2.1.2 Quest Diagnostics Major Business
2.1.3 Quest Diagnostics Drugs of Abuse Testing Product and Solutions
2.1.4 Quest Diagnostics Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Quest Diagnostics Recent Developments and Future Plans
2.2 F. Hoffmann La-Roche
2.2.1 F. Hoffmann La-Roche Details
2.2.2 F. Hoffmann La-Roche Major Business
2.2.3 F. Hoffmann La-Roche Drugs of Abuse Testing Product and Solutions
2.2.4 F. Hoffmann La-Roche Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann La-Roche Recent Developments and Future Plans
2.3 Siemens
2.3.1 Siemens Details
2.3.2 Siemens Major Business
2.3.3 Siemens Drugs of Abuse Testing Product and Solutions
2.3.4 Siemens Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Siemens Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Drugs of Abuse Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Drugs of Abuse Testing Product and Solutions
2.5.4 Abbott Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Shimadzu
2.6.1 Shimadzu Details
2.6.2 Shimadzu Major Business
2.6.3 Shimadzu Drugs of Abuse Testing Product and Solutions
2.6.4 Shimadzu Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Shimadzu Recent Developments and Future Plans
2.7 Laboratory Corporation of America
2.7.1 Laboratory Corporation of America Details
2.7.2 Laboratory Corporation of America Major Business
2.7.3 Laboratory Corporation of America Drugs of Abuse Testing Product and Solutions
2.7.4 Laboratory Corporation of America Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Laboratory Corporation of America Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drugs of Abuse Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Drugs of Abuse Testing Players Market Share
3.2.2 Top 10 Drugs of Abuse Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Drugs of Abuse Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Drugs of Abuse Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Drugs of Abuse Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Drugs of Abuse Testing Revenue Market Share by Application (2016-2021)
5.2 Drugs of Abuse Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Drugs of Abuse Testing Revenue by Type (2016-2026)
6.2 North America Drugs of Abuse Testing Revenue by Application (2016-2026)
6.3 North America Drugs of Abuse Testing Market Size by Country
6.3.1 North America Drugs of Abuse Testing Revenue by Country (2016-2026)
6.3.2 United States Drugs of Abuse Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Drugs of Abuse Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Drugs of Abuse Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Drugs of Abuse Testing Revenue by Type (2016-2026)
7.2 Europe Drugs of Abuse Testing Revenue by Application (2016-2026)
7.3 Europe Drugs of Abuse Testing Market Size by Country
7.3.1 Europe Drugs of Abuse Testing Revenue by Country (2016-2026)
7.3.2 Germany Drugs of Abuse Testing Market Size and Forecast (2016-2026)
7.3.3 France Drugs of Abuse Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Drugs of Abuse Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Drugs of Abuse Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Drugs of Abuse Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Drugs of Abuse Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Drugs of Abuse Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Drugs of Abuse Testing Market Size by Region
8.3.1 Asia-Pacific Drugs of Abuse Testing Revenue by Region (2016-2026)
8.3.2 China Drugs of Abuse Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Drugs of Abuse Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Drugs of Abuse Testing Market Size and Forecast (2016-2026)
8.3.5 India Drugs of Abuse Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Drugs of Abuse Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Drugs of Abuse Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Drugs of Abuse Testing Revenue by Type (2016-2026)
9.2 South America Drugs of Abuse Testing Revenue by Application (2016-2026)
9.3 South America Drugs of Abuse Testing Market Size by Country
9.3.1 South America Drugs of Abuse Testing Revenue by Country (2016-2026)
9.3.2 Brazil Drugs of Abuse Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Drugs of Abuse Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Drugs of Abuse Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Drugs of Abuse Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Drugs of Abuse Testing Market Size by Country
10.3.1 Middle East & Africa Drugs of Abuse Testing Revenue by Country (2016-2026)
10.3.2 Turkey Drugs of Abuse Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Drugs of Abuse Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Drugs of Abuse Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Drugs of Abuse Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Drugs of Abuse Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Drugs of Abuse Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Drugs of Abuse Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Drugs of Abuse Testing Revenue Market Share by Region (2021-2026)
Table 6. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. Quest Diagnostics Major Business
Table 8. Quest Diagnostics Drugs of Abuse Testing Product and Solutions
Table 9. Quest Diagnostics Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann La-Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann La-Roche Major Business
Table 12. F. Hoffmann La-Roche Drugs of Abuse Testing Product and Solutions
Table 13. F. Hoffmann La-Roche Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Siemens Corporate Information, Head Office, and Major Competitors
Table 15. Siemens Major Business
Table 16. Siemens Drugs of Abuse Testing Product and Solutions
Table 17. Siemens Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Drugs of Abuse Testing Product and Solutions
Table 21. Thermo Fisher Scientific Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Drugs of Abuse Testing Product and Solutions
Table 25. Abbott Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Shimadzu Corporate Information, Head Office, and Major Competitors
Table 27. Shimadzu Major Business
Table 28. Shimadzu Drugs of Abuse Testing Product and Solutions
Table 29. Shimadzu Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Laboratory Corporation of America Corporate Information, Head Office, and Major Competitors
Table 31. Laboratory Corporation of America Major Business
Table 32. Laboratory Corporation of America Drugs of Abuse Testing Product and Solutions
Table 33. Laboratory Corporation of America Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Drugs of Abuse Testing Revenue (USD Million) by Players (2019-2021)
Table 35. Global Drugs of Abuse Testing Revenue Share by Players (2019-2021)
Table 36. Breakdown of Drugs of Abuse Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Drugs of Abuse Testing Players Head Office, Products and Services Provided
Table 38. Drugs of Abuse Testing Mergers & Acquisitions in the Past Five Years
Table 39. Drugs of Abuse Testing New Entrants and Expansion Plans
Table 40. Global Drugs of Abuse Testing Revenue (USD Million) by Type (2016-2021)
Table 41. Global Drugs of Abuse Testing Revenue Share by Type (2016-2021)
Table 42. Global Drugs of Abuse Testing Revenue Forecast by Type (2021-2026)
Table 43. Global Drugs of Abuse Testing Revenue by Application (2016-2021)
Table 44. Global Drugs of Abuse Testing Revenue Forecast by Application (2021-2026)
Table 45. North America Drugs of Abuse Testing Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Drugs of Abuse Testing Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Drugs of Abuse Testing Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Drugs of Abuse Testing Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Drugs of Abuse Testing Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Drugs of Abuse Testing Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Drugs of Abuse Testing Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Drugs of Abuse Testing Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Drugs of Abuse Testing Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Drugs of Abuse Testing Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Drugs of Abuse Testing Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Drugs of Abuse Testing Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Drugs of Abuse Testing Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Drugs of Abuse Testing Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Drugs of Abuse Testing Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Drugs of Abuse Testing Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Drugs of Abuse Testing Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Drugs of Abuse Testing Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Drugs of Abuse Testing Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Drugs of Abuse Testing Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Drugs of Abuse Testing Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Drugs of Abuse Testing Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Drugs of Abuse Testing Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Drugs of Abuse Testing Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Drugs of Abuse Testing Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Drugs of Abuse Testing Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Drugs of Abuse Testing Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Drugs of Abuse Testing Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Drugs of Abuse Testing Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Drugs of Abuse Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Drugs of Abuse Testing Picture
Figure 2. Global Drugs of Abuse Testing Revenue Market Share by Type in 2020
Figure 3. Psychostimulants
Figure 4. Narcotic
Figure 5. Hallucinogens
Figure 6. Sedatives
Figure 7. Others
Figure 8. Drugs of Abuse Testing Revenue Market Share by Application in 2020
Figure 9. Hospitals Picture
Figure 10. Diagnostics Laboratories Picture
Figure 11. Forensic Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Drugs of Abuse Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Drugs of Abuse Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Drugs of Abuse Testing Revenue Market Share by Region (2016-2026)
Figure 16. Global Drugs of Abuse Testing Revenue Market Share by Region in 2020
Figure 17. North America Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Drugs of Abuse Testing Market Drivers
Figure 23. Drugs of Abuse Testing Market Restraints
Figure 24. Drugs of Abuse Testing Market Trends
Figure 25. Quest Diagnostics Recent Developments and Future Plans
Figure 26. F. Hoffmann La-Roche Recent Developments and Future Plans
Figure 27. Siemens Recent Developments and Future Plans
Figure 28. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 29. Abbott Recent Developments and Future Plans
Figure 30. Shimadzu Recent Developments and Future Plans
Figure 31. Laboratory Corporation of America Recent Developments and Future Plans
Figure 32. Global Drugs of Abuse Testing Revenue Share by Players in 2020
Figure 33. Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Drugs of Abuse Testing Revenue Market Share in 2020
Figure 35. Global Top 10 Players Drugs of Abuse Testing Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Drugs of Abuse Testing Revenue Share by Type in 2020
Figure 38. Global Drugs of Abuse Testing Market Share Forecast by Type (2021-2026)
Figure 39. Global Drugs of Abuse Testing Revenue Share by Application in 2020
Figure 40. Global Drugs of Abuse Testing Market Share Forecast by Application (2021-2026)
Figure 41. North America Drugs of Abuse Testing Sales Market Share by Type (2016-2026)
Figure 42. North America Drugs of Abuse Testing Sales Market Share by Application (2016-2026)
Figure 43. North America Drugs of Abuse Testing Revenue Market Share by Country (2016-2026)
Figure 44. United States Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Drugs of Abuse Testing Sales Market Share by Type (2016-2026)
Figure 48. Europe Drugs of Abuse Testing Sales Market Share by Application (2016-2026)
Figure 49. Europe Drugs of Abuse Testing Revenue Market Share by Country (2016-2026)
Figure 50. Germany Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Drugs of Abuse Testing Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Drugs of Abuse Testing Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Drugs of Abuse Testing Revenue Market Share by Region (2016-2026)
Figure 58. China Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Drugs of Abuse Testing Sales Market Share by Type (2016-2026)
Figure 65. South America Drugs of Abuse Testing Sales Market Share by Application (2016-2026)
Figure 66. South America Drugs of Abuse Testing Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Drugs of Abuse Testing Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Drugs of Abuse Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Buy
